Which of the following is not a feature of Papillary carcinoma of thyroid?
Most papillary carcinomas have gain-of-function mutations or rearrangements involving: RET gene NTRK1 receptor tyrosine kinases Serine/threonine kinase BRAF, which is component of MAPK pathway. RAS mutations are seen in follicular carcinoma of thyroid.
Rearrangement of RET gene
Rearrangement of NTRK1 gene
Mutation of BRAF gene
Mutation of RAS gene
Thyroid Tumor